Hosted on MSN18h
Scientists discover dogs are entering a new phase of evolution
The dogs performed this behavioral test twice, once after receiving a dose of oxytocin nasal spray, and once after receiving a dose ... herding and guarding their home and the people in it - ...
'We are very hopeful' | New nasal spray could delay Alzheimer's by years, researchers say
Researchers at Texas A&M University have developed a nasal spray shown to delay disease progression in animals -- fueling ...
KSTP-TV2d
Patients could get at-home flu vaccine as early as next year
The at-home FluMist vaccine will be for patients ages 2 to 49 years old. Patients can place an order online, complete a ...
Scientists Develop Breakthrough Nasal Spray That Could Delay Alzheimer’s by Over a Decade
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
Philadelphia Tribune2d
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The U.S. Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter decongestants – from the market, citing evidence that it ...
CNET3d
Still Need a Flu Vaccine? Now May Be a Good Time to Get One
Protection from shots like the flu vaccine typically takes a couple of weeks to kick in, so getting one now may offer ...
ARS Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Updates
Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...
Hosted on MSN3d
1 in 5 Adults Report Anxiety, Depression; Esketamine Label Update; Autism Dx Up 175%
The FDA updated a warning on the label of esketamine nasal spray (Spravato) about the long-term cognitive ... (JAMA Network ...
Bitcoin Magazine3d
The Digit Addiction Pandemic
As bad as such addictions might sound, and as widespread as they are, the current global addiction is yet worse: the ...
Milestone Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Regulatory and Corporate Update
MONTREAL and CHARLOTTE, N.C., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the third quarter ended September 30, 2024 and ...